[HTML][HTML] Optimal respiratory syncytial virus intervention programmes using nirsevimab in England and Wales

D Hodgson, M Koltai, F Krauer, S Flasche, M Jit… - Vaccine, 2022 - Elsevier
Abstract Introduction Respiratory Syncytial Virus (RSV) is a major cause of acute lower
respiratory tract infections (ALRI) in infants. There are no licensed vaccines and only one …

Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study

F Krauer, F Guenther, M Treskova-Schwarzbach… - BMC medicine, 2024 - Springer
Background Recently, several novel RSV immunisation products that protect infants and
older adults against RSV disease have been licensed in Europe. We estimated the …

[HTML][HTML] Predicting the impact of COVID-19 non-pharmaceutical intervention on short-and medium-term dynamics of enterovirus D68 in the US

SW Park, K Messacar, DC Douek, AB Spaulding… - Epidemics, 2024 - Elsevier
Recent outbreaks of enterovirus D68 (EV-D68) infections, and their causal linkage with
acute flaccid myelitis (AFM), continue to pose a serious public health concern. During 2020 …

Turing. jl: a general-purpose probabilistic programming language

TE Fjelde, K Xu, D Widmann, M Tarek, C Pfiffer… - ACM Transactions on …, 2025 - dl.acm.org
Probabilistic programming languages (PPLs) are becoming increasingly important in many
scientific disciplines, such as economics, epidemiology, and biology, to extract meaning …